Patents by Inventor Lars Vorland

Lars Vorland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bioactive peptides
    Patent number: 8143211
    Abstract: The present invention provides a cytotoxic 7 to 25-mer peptide with three or more cationic residues which has one or more non-generic bulky and lipophilic amino acids, as well as esters, amides, salts and cyclic derivatives thereof as well as methods of preparing the peptides, pharmaceutical compositions containing them, and their use as medicaments, particularly as antibacterial or antitumor agents.
    Type: Grant
    Filed: July 2, 2008
    Date of Patent: March 27, 2012
    Assignee: Lytix Biopharma AS
    Inventors: John Sigurd Svendsen, Øystein Rekdal, Baldur Sveinbjørnsson, Lars Vorland
  • Bioactive peptides
    Publication number: 20080287346
    Abstract: The present invention provides a cytotoxic 7 to 25-mer peptide with three or more cationic residues which has one or more non-generic bulky and lipophilic amino acids, as well as esters, amides, salts and cyclic derivatives thereof as well as methods of preparing the peptides, pharmaceutical compositions containing them, and their use as medicaments, particularly as antibacterial or antitumor agents.
    Type: Application
    Filed: July 2, 2008
    Publication date: November 20, 2008
    Inventors: John Sigurd Svendsen, Oystein Rekdal, Baldur Sveinbjornsson, Lars Vorland
  • Bioactive peptides
    Patent number: 7439228
    Abstract: The present invention provides a cytotoxic 7 to 25-mer peptide with three or more catonic residues which has one or more non-genetic bulky and lipophilic amino acids, as well as esters, amides, salts and cyclic derivatives thereof as well as methods of preparing the peptides, pharmaceutical compositions containing them, and their use as medicaments, particularly as antibacterial or antitumor agents.
    Type: Grant
    Filed: February 27, 2001
    Date of Patent: October 21, 2008
    Assignee: Lytix Biopharma AS
    Inventors: John Sigurd Svendsen, Øystein Rekdal, Baldur Sveinbjørnsson, Lars Vorland
  • Cytotoxic modified lactoferrin peptides
    Patent number: 6890902
    Abstract: The present invention provides a modified lactoferrin peptide which is cytotoxic, 7 to 25 amino acids in length, with three or more cationic residues and which has one or more extra bulky and lipophilic amino acids as compared to the native lactoferrin sequence, as well as esters, amides, salts and cyclic derivatives thereof as well as methods of preparing such peptides, pharmaceutical compositions containing such peptides and use of the peptides as medicaments, particularly as antibacterials or anti-tumoural agents.
    Type: Grant
    Filed: February 27, 2001
    Date of Patent: May 10, 2005
    Assignee: Alpharma AS
    Inventors: John Sigurd Svendsen, Oystein Rekdal, Baldur Sveinbjornsson, Lars Vorland
  • Bioactive peptides
    Publication number: 20030148936
    Abstract: The present invention provides a cytotoxic 7 to 25-mer peptide with three or more catonic residues which has one or more non-genetic bulky and lipophilic amino acids, as well as esters, amides, salts and cyclic derivatives thereof as well as methods of preparing the peptides, pharmaceutical compositions containing them, and their use as medicaments, particularly as antibacterial or antitumor agents.
    Type: Application
    Filed: February 27, 2001
    Publication date: August 7, 2003
    Applicant: ALPHARMA AS.
    Inventors: John Sigurd Svendsen, Oystein Rekdal, Baldur Sveinbjornsson, Lars Vorland
  • Bioactive peptides
    Publication number: 20030022821
    Abstract: The present invention provides a modified lactoferrin peptide which is cytotoxic, 7 to 25 amino acids in length, with three or more cationic residues and which has one or more extra bulky and lipophilic amino acids as compared to the native lactoferrin sequence, as well as esters, amides, salts and cyclic derivatives thereof as well as methods of preparing such peptides, pharmaceutical compositions containing such peptides and use of the peptides as medicaments, particularly as antibacterials or anti-tumoural agents.
    Type: Application
    Filed: February 27, 2001
    Publication date: January 30, 2003
    Applicant: ALPHARMA AS
    Inventors: John Sigurd Svenden, Oystein Rekdal, Baldur Sveinbjornsson, Lars Vorland